In 2012, rapid molecular DNA diagnostic methods recommended by WHO were implemented in 12 regions of Ukraine. Since 2013, all 27 regions of Ukraine are provided with access to rapid diagnostic methods. In the course of equipment installation across the regions, installation trainings were held by a maintenance engineer at all laboratories. The responsible experts made two monitoring visits to each region in the course of launching rapid diagnostic methods in order to ensure on-the-job training. In 2011 patients with sensitive TB had the limited access to the first-line TB drugs. In 2012-2013, availability of first-line drugs was 100%. In 2011 patients with MDR-TB were provided with second-line drugs for 79%, in 2012 – for 95%, in 2013 – for 102%.*
* Data sourced from the report form MDR TB 07 for the respective years.
8. New tools should only be introduced, such as the rapid diagnosis of TB, when testing results are proven reliable and all new cases detected can be treated with a full course of second-line TB drugs.